Barrons Retirement: Eli Lilly Stock Is Surging on Hope for Alzheimer’s Drug. Analyst Says It Won’t Last.

Eli Lilly Stock Is Surging on Hope for Alzheimer’s Drug. Analyst Says It Won’t Last.
The company has said it will provide detailed data on the treatment on March 13. The stock is up some 19% over the past week.